Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 53: 1782-1791, 2007. First published August 16, 2007; 10.1373/clinchem.2007.087650
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow 087650.Supplemental Data
Right arrow All Versions of this Article:
clinchem.2007.087650v1
53/10/1782    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McMorran, B. J.
Right arrow Articles by Wainwright, B. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McMorran, B. J.
Right arrow Articles by Wainwright, B. J.
Related Collections
Right arrow Proteomics and Protein Markers
(Clinical Chemistry. 2007;53:1782-1791.)
© 2007 American Association for Clinical Chemistry, Inc.


Proteomics and Protein Markers

Novel Neutrophil-Derived Proteins in Bronchoalveolar Lavage Fluid Indicate an Exaggerated Inflammatory Response in Pediatric Cystic Fibrosis Patients

Brendan J. McMorran1,a, Severine A. Ouvry Patat2, John B. Carlin3,4, Keith Grimwood5, Alun Jones6, David S. Armstrong7, John C. Galati3, Peter J. Cooper8, Catherine A. Byrnes9, Paul W. Francis10, Colin F. Robertson3, David A. Hume6, Christoph H. Borchers11, Claire E. Wainwright10,12 and Brandon J. Wainwright6

1 Menzies Research Institute, University of Tasmania, Hobart, Australia.
2 Department of Biochemistry and Biophysics, University of North Carolina at Chapel Hill, Chapel Hill, NC.
3 Murdoch Children’s Research Institute, Royal Children’s Hospital, Melbourne, Australia.
4 Department of Paediatrics, University of Melbourne, Melbourne, Australia.
5 Department of Paediatrics and Child Health, Wellington School of Medicine and Health Sciences, University of Otago, Wellington, New Zealand.
6 Institute for Molecular Bioscience, University of Queensland, Brisbane, Australia.
7 Department of Paediatrics, Monash University, Melbourne, Australia.
8 Children’s Hospital, Sydney, Australia.
9 Starship Hospital, Auckland, New Zealand.
10 Royal Children’s Hospital, Brisbane, Australia.
11 University of Victoria–Genome BC Proteomics Centre, Victoria, British Columbia, Canada.
12 School of Medicine, University of Queensland, Brisbane, Australia.

aAddress correspondence to this author at: University of Tasmania, Menzies Research Institute, Private Bag 109, Hobart, Tasmania 7001, Australia. Fax 61-3-62267411; e-mail brendan.mcmorran{at}utas.edu.au.

Background: Airway inflammation in cystic fibrosis (CF) is exaggerated and characterized by neutrophil-mediated tissue destruction, but its genesis and mechanisms remain poorly understood. To further define the pulmonary inflammatory response, we conducted a proteome-based screen of bronchoalveolar lavage fluid (BALF) collected from young children with and without CF experiencing endobronchial infection.

Methods: We collected BALF samples from 45 children younger than 5 years and grouped them according to the presence of respiratory pathogens: ≥1 x 105 colony-forming units (CFU)/mL BALF (18 and 12 samples with and without CF, respectively) and <1 x 105 CFU/mL (23 and 15 samples). BALF proteins were analyzed with SELDI-TOF mass spectrometry (MS) and H4 ProteinChips®. Proteins were identified and characterized using trypsin digestion, tandem MS, Fourier transform ion cyclotron resonance MS, immunoblotting, and ELISA.

Results: The SELDI-TOF MS BALF profiles contained 53 unique, reliably detected proteins. Peak intensities of 24 proteins differed significantly between the CF and non-CF samples. They included the neutrophil proteins, {alpha}-defensin 1 and 2, S100A8, S100A9, and S100A12, as well as novel forms of S100A8 and S100A12 with equivalent C-terminal deletions. Peak intensities of these neutrophil proteins and immunoreactive concentrations of selected examples were significantly higher in CF than non-CF samples.

Conclusions: Small neutrophil-derived BALF proteins, including novel C-terminal truncated forms of S100A proteins, are easily detected with SELDI-TOF MS. Concentrations of these molecules are abnormally high in early CF lung disease. The data provide new insights into CF lung disease and identify novel proteins strongly associated with CF airway inflammation.




The following articles in journals at HighWire Press have cited this article:


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Makam, D. Diaz, J. Laval, Y. Gernez, C. K. Conrad, C. E. Dunn, Z. A. Davies, R. B. Moss, L. A. Herzenberg, L. A. Herzenberg, et al.
Activation of critical, host-induced, metabolic and stress pathways marks neutrophil entry into cystic fibrosis lungs
PNAS, April 7, 2009; 106(14): 5779 - 5783.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
C. L. Ventura, R. Higdon, L. Hohmann, D. Martin, E. Kolker, H. D. Liggitt, S. J. Skerrett, and C. E. Rubens
Staphylococcus aureus Elicits Marked Alterations in the Airway Proteome during Early Pneumonia
Infect. Immun., December 1, 2008; 76(12): 5862 - 5872.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
R. D. Gray, G. MacGregor, D. Noble, M. Imrie, M. Dewar, A. C. Boyd, J. A. Innes, D. J. Porteous, and A. P. Greening
Sputum Proteomics in Inflammatory and Suppurative Respiratory Diseases
Am. J. Respir. Crit. Care Med., September 1, 2008; 178(5): 444 - 452.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
D. de Seny, M. Fillet, C. Ribbens, R. Maree, M.-A. Meuwis, L. Lutteri, J.-P. Chapelle, L. Wehenkel, E. Louis, M.-P. Merville, et al.
Monomeric Calgranulins Measured by SELDI-TOF Mass Spectrometry and Calprotectin Measured by ELISA as Biomarkers in Arthritis
Clin. Chem., June 1, 2008; 54(6): 1066 - 1075.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American Association for Clinical Chemistry.